Dr Khalid Al Rubeaan is a Professor and Senior Endocrinologist at College of Medicine, King Saud University, Riyadh, Saudi Arabia, with major interests in endocrine diseases especially Diabetes Mellitus. His main areas of interest include basic research, education, prevention and epidemiology of Diabetes Mellitus in Saudi Arabia and Middle East. He is the Executive Director of Strategic Center for Diabetes Research and Editor-in-chief of International Journal of Diabetes Mellitus and Head of Saudi National Diabetes Registry. He is a member of many associations and has numerous publications in the form of book chapters and scientific papers covering various aspects of Diabetes Mellitus. His achievements include many national and international awards from Government agencies as well as research and academic institutions. He also holds patent in the field of Nano Technology & IT for the management of Diabetes Mellitus.
Chronic low-grade inflammation is a significant factor in the development of obesity associated diabetes. This is supported by recent studies suggesting that endotoxin, derived from gut flora, may…
This study aims to identify which among the metabolic syndrome (MS) definitions are closely associated with pathological levels of leptin, adiponectin, resistin, tumour necrosis…
بواسطة
Al-Daghri NM1, Al-Attas OS, Al-Rubeaan K, Sallam R
Abstract: The aim of the study was to determine surgical indication and complication of subtotal thyroidectomy in patients being treated for Graves’ disease at King Khalid…
بواسطة
Usman H , Malabu UH, Assim Alfadda, Riad A. Sulimani, Khalid A. Al-Rubeaan, Atallah D. Al-Ruhaily, Mona A. Fouda, Mohamed A. Al-Maatouq, Abdulkarim A. El-Bakry